A LONG SURVIVOR AFTER RESECTION OF CANCER OF THE PANCREAS BODY OCCURRED AS THE THIRD MALIGNANCY OF HETEROCHRONOUS TRIPLE CANCER

• Published in: Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) Vol. 66; no. 5; pp. 1179 - 1183
• Main Authors: TOYOSHIMA, Satoshi, NAKAMORI, Mari, MORI, Toshinao, NISHIHARA, Kazuyoshi, KATSUMOTO, Fujio, MITSUYAMA, Shoshu, YANAI, Kosuke
• Format: Journal Article
• Language: English
• Published: Japan Surgical Association 2005
• ISSN: 1345-2843; 1882-5133
• DOI: 10.3919/jjsa.66.1179

A 64-year-old woman diagnosed as having right occult breast cancer underwent a right extended radical mastectomy (Stage III, solid tubular carcinoma) in February, 1990. Tamoxifen and tegafur uracil (UFT) were administered orally as adjuvant chemotherapy for five years after the operation. She was admitted to the department of gynecology in our hospital because of genital bleeding in May, 1998. She was diagnosed as having uterine body cancer, and underwent a semi-radical hysterectomy (Stage IIIc, small cell carcinoma), followed by 6 courses of adjuvant chemotherapy with carboplatin+etoposide. In March, 1999, periodic follow-up abdominal ultrasonography revealed pancreas body cancer. Distal pancreatectomy with intraoperative radiation therapy (25Gy)was performed (Stage II, well differentiated tubular adenocarcinoma). No signs of recurrence have been observed for five years and 10 months after the operation for the pancreas cancer. In the present case, the follow up study for the uterine cancer led to the early detection of the pancreatic cancer that resulted in the long-term survival of the patient.